Eyes In Dogs Research Articles

Trans‐corneal reduction of anterior lens luxation in dogs with lens instability: a retrospective study of 19 dogs (2010–2013)

To evaluate the success rate and outcome of trans-corneal reduction of anterior lens luxation (TR-ALL) in dogs with lens instability. Nineteen dogs with anterior lens luxation. Medical records of dogs with anterior lens luxation (ALL) were reviewed: dogs were included if TR-ALL was performed followed by medical therapy in the form of topical 0.005% latanoprost ophthalmic solution. The duration of ALL, vision status, ophthalmic examination abnormalities, reason for performing TR-ALL and details of TR-ALL were recorded. Success rate for TR-ALL as well as postprocedure complications were also assessed. Twenty eyes from 19 dogs met the inclusion criteria. Median age was 6.5 years (0.3-15 years) and 47% were terriers (9/19). Successful TR-ALL was achieved in 85% of eyes (17/20); failure was attributed to posterior synechia or vitreous expansion. Short-term complications included corneal ulceration (2/20) and anterior uveitis (3/20); recurrence of anterior luxation occurred in only one dog. Median follow-up for visual eyes (11) following successful TR-ALL was 353 days (range of 1 to 1182 days). Vision was retained in 54.5% (6/11) of eyes with a median time to vision loss of 12 months as a result of glaucoma or presumed retinal detachment. Trans-corneal reduction of ALL provides a non-surgical alternative to intracapsular lens extraction (visual eyes) or enucleation (nonvisual eyes) in dogs. Long-term visual outcome of TR-ALL is comparable to intracapsular lens extraction for ALL.

How to…

Abstract Horner’s syndrome is a common neurological disorder affecting the eyes in both dogs and cats. Symptoms, diagnosis and treatment are described.

A and B mode ultrasonography in preoperative evaluation of lens and posterior segment of dogs eyes with cataract

Ultrasonography of the lens and posterior segment is an indispensable step in the preoperative evaluation of dogs with cataracts, since ophthalmoscopy is not feasible when there is opacification of the lens. This study evaluated the echographic conditions of cataractous lens and fundus of the eye in dogs affected by cataracts. The study was conducted in 30 dogs (56 eyes), 10 males and 20 females, with different types of cataracts at different stages of development. Echography in A and B modes, simultaneously, was carried out for the examination of the lens and posterior segment. The examinations revealed anterior cortical, posterior cortical and nuclear cataract in 12 eyes (21.4%), anterior cortical, posterior cortical, nuclear and posterior capsular in 23 eyes (41%), anterior cortical, posterior cortical and posterior capsular cataract in one eye (1.7%), anterior cortical and nuclear cataract in one eye (1.7%), anterior cortical, nuclear and posterior capsular cataract in five eyes (8.9%), and anterior cortical cataract in seven eyes (12.5%). Abnormal ultrasonographic alterations were observed in the posterior segment in 26 eyes evaluated (46.4%). Vitreal degeneration was detected in 12 eyes (21.4%), images of vitreal exudate or hemorrhage in seven eyes (12.5%), persistence of hyaloid artery in four eyes (7.1%) and lens subluxation in three eyes (5.3%). The results obtained reiterate the importance of ultrasonography in canine patients presented for cataract surgery given that alterations of the posterior segment are difficult to identify in a clinical examination when the lens is opacified.

Evaluation of matrix metalloproteinase concentrations in precorneal tear film from dogs with Pseudomonas aeruginosa–associated keratitis

To evaluate the changes in concentrations of matrix metalloproteinase (MMP)-2 and MMP-9 in the precorneal tear film of dogs with Pseudomonas aeruginosa-associated keratitis during corneal healing and stromal remodeling. 10 dogs with unilateral P aeruginosa-associated keratitis and 10 clinically normal dogs. Precorneal tear film samples were collected from both eyes of 10 dogs with unilateral P aeruginosa-associated keratitis on the day of admission to the hospital and then at various time points until complete healing of the cornea was achieved. Precorneal tear film samples were also collected from both eyes of 10 clinically normal adult dogs (control group). Concentrations of MMP-2 and MMP-9 in precorneal tear film samples from each group were determined via gelatin zymography for comparison. The proteolytic processes in the ulcerated eyes decreased as corneal healing progressed. On the day of admission, concentrations of latent and active forms of MMP-2 and MMP-9 in ulcerated eyes were significantly higher than values in the contralateral unaffected eyes in dogs with P aeruginosa-associated keratitis; concentrations of latent MMP-2 and MMP-9 were also greater than control group values. Concentrations of latent and active forms of MMP-2 and MMP-9 in the healed eyes of dogs with P aeruginosa-associated keratitis were significantly lower than concentrations in the ulcerated eyes on the day of admission. Results suggest that reduction of precorneal tear film concentrations of MMPs by use of proteinase inhibitors may be effective in the treatment of dogs with P aeruginosa-associated keratitis.

Retinopathy associated with ivermectin toxicosis in two dogs

2 dogs (dogs 1 and 2) were examined for sudden onset of blindness. Both dogs had mild obtundation and mydriasis in both eyes. It was thought that dog 1 may have ingested ivermectin; dog 2 had been treated with ivermectin for demodectic mange. On initial examination, both dogs had mydriasis and decreased pupillary light reflexes in both eyes. Dog 1 had an absent menace response bilaterally. Fundic examination of both eyes in both dogs revealed regions of multifocal retinal edema and folds with low-lying retinal separation. The electroretinogram was extinguished in dog 1 and attenuated in dog 2. Ivermectin was detected in serum samples from both dogs. Both dogs made a complete clinical recovery following cessation of exposure to ivermectin; electroretinographic findings improved, and retinal edema resolved with some residual chorioretinal scarring. To our knowledge, this is the first report of resolution of retinal edema and electroretinographic changes associated with ivermectin toxicosis in dogs. In dogs that develop blindness suddenly, fundic examination, electroretinography, and assessment of serum ivermectin concentration are diagnostically useful, even if exposure to ivermectin is unknown.

POTENTIAL FOR INTENSITY‐MODULATED RADIATION THERAPY TO PERMIT DOSE ESCALATION FOR CANINE NASAL CANCER

We evaluated the impact of inverse planned intensity-modulated radiation therapy (IMRT) on the dose-volume histograms (DVHs) and on the normal tissue complication probabilities (NTCPs) of brain and eyes in dogs with nasal tumors. Nine dogs with large, caudally located nasal tumors were planned using conventional techniques and inverse planned IMRT for a total prescribed dose of 52.5 Gy in 3.5 Gy fractions. The equivalent uniform dose for brain and eyes was calculated to estimate the normal tissue complication probability (NTCP) of these organs. The NTCP values as well as the DVHs were used to compare the treatment plans. The dose distribution in IMRT plans was more conformal than in conventional plans. The average dose delivered to one-third of the brain was 10 Gy lower with the IMRT plan compared with conventional planning. The mean partial brain volume receiving 43.6 Gy or more was reduced by 25.6% with IMRT. As a consequence, the NTCPs were also significantly lower in the IMRT plans. The mean NTCP of brain was two times lower and at least one eye could be saved in all patients planed with IMRT. Another possibility with IMRT is dose escalation in the target to improve tumor control while keeping the NTCPs at the same level as for conventional planning. Veterinary

Evaluation of acoustic wave propagation velocities in the ocular lens and vitreous tissues of pigs, dogs, and rabbits

To evaluate propagation velocity of acoustic waves through the lens and vitreous body of pigs, dogs, and rabbits and determine whether there were associations between acoustic wave speed and age, temperature, and time after enucleation. 9 pig, 40 dog, and 20 rabbit lenses and 16 pig, 17 dog, and 23 rabbit vitreous bodies. Acoustic wave velocities through the ocular structures were measured by use of the substitution technique. Mean sound wave velocities in lenses of pigs, dogs, and rabbits were 1,681, 1,707, and 1,731 m/s, respectively, at 36 degrees C. Mean sound wave velocities in the vitreous body of pigs, dogs, and rabbits were 1,535, 1,535, and 1,534 m/s, respectively, at 38 degrees C. The sound wave speed through the vitreous humor, but not the lens, increased linearly with temperature. An association between wave speed and age was observed in the rabbit tissues. Time after enucleation did not affect the velocity of sound in the lens or vitreous body. The sound wave speed conversion factors for lenses, calculated with respect to human ocular tissue at 36 degrees C, were 1.024, 1.040, and 1.055 for pig, dog, and rabbit lenses, respectively. Conversion factors for the speed of sound through lens tissues are needed to avoid underestimation of the thickness of the lens and axial length of the eye in dogs during comparative A-mode ultrasound examinations. These findings are important for accurate calculation of intraocular lens power required to achieve emmetropia in veterinary patients after surgical lens extraction.

Effects of intracameral injection of preservative-free lidocaine on the anterior segment of the eyes in dogs

To evaluate effects of intracameral injection of preservative-free 1% and 2% lidocaine hydrochloride solution on the anterior segment of the eyes in dogs. 16 adult healthy dogs (8 male and 8 female) judged to be free of ocular disease. Dogs were randomly assigned to 2 groups of 8 dogs each. Group 1 dogs received an intracameral injection of 0.10 mL of preservative-free 1% lidocaine solution in the designated eye, and group 2 dogs received 0.10 mL of preservative-free 2% lidocaine solution in the designated eye. After injection, intraocular pressure was measured every 12 hours for 48 hours and then every 24 hours until 168 hours after injection. Slit-lamp biomicroscopy was performed preceding intracameral injection, 8 hours after injection, and then every 24 hours until 168 hours after injection. Ultrasonic pachymetry and specular microscopy were performed preceding intracameral injection and 72 and 168 hours after injection. Corneal thickness and endothelial cell density and morphology were compared with baseline measurements. No significant differences were found in intraocular pressure, corneal thickness, endothelial cell density, and morphologic features in either group, compared with baseline. A significant difference in aqueous flare was found for treated and control eyes 8, 24, and 48 hours after injection, compared with baseline. No significant difference in aqueous flare was found between treated and control eyes within either group. No adverse ocular effects were detected after intracameral injection of preservative-free 1% or 2% lidocaine solution; thus, its use would be safe for intraocular pain management in dogs.

In vivo gene therapy in young and adult RPE65-/- dogs produces long-term visual improvement.

Defects in the RPE65 gene, which is selectively expressed in the retinal pigment epithelium (RPE), result in blindness and gradual photoreceptor cell degeneration. Experiments were conducted to assess the efficacy of gene replacement therapy in restoring retinal function in RPE65-/- dogs. Long-term effects of RPE65 gene therapy were assessed using visual behavioral testing and electroretinographic (ERG) recordings at 10-12 weeks and 6-9 months after surgery in five affected dogs. Subretinal injections of similar dosages of two constructs were performed in affected dogs at the ages of 4-30 months: rAAV.RPE65 into one eye and, in four of five dogs, rAAV.GFP contralaterally. Before surgery all RPE65-/- dogs were behaviorally blind with either no or very low-amplitude ERG responses to light stimuli. Marked improvements in visual behavior and ERG responses were observed as early as 4 weeks after surgery in affected animals. Except for light-adapted 50 Hz ERG flicker responses, all ERG parameters tested increased significantly in the eyes treated with the rAAV.RPE65 construct at the early follow-up. Gradual progressive improvements in ERG responses were observed in the RPE65-treated eyes over time. An unexpected finding was that on long-term follow-up, marked improvement of photopic ERG responses were also observed in the contralateral control eye in both young and older dogs. These results are promising for future clinical trials of human patients with retinal degenerative diseases, such as Leber congenital amaurosis, that result from RPE65 gene defects.

犬の眼および鼻粘膜に対する尿素系路面凍結防止剤の急性刺激作用

犬の眼および鼻粘膜に対する尿素系路面凍結防止剤の急性刺激作用

Heterogeneity of SPECT bull's-eyes in normal dogs: comparison of attenuation compensation algorithms

In normal dogs, SPECT /sup 99m/Tc Sestamibi (MIBI) and /sup 201/Tl myocardial perfusion images reconstructed with filtered backprojection (FBP) show a large decrease of counts in the septal wall (S) compared to the lateral wall (L). We evaluated the iterative method of Chang (1978) at 0 and 1 iterations (Chang0 and Chang1), and the Maximum Likelihood-Expectation Maximization with attenuation compensation (ML-EM-ATN) algorithm on data acquired from 5 normal dogs and from simulated projection data using a homogeneous count-density model of a normal canine myocardium in the attenuation field measured in one dog. Mean counts in the S and L regions were calculated from maximum-count circumferential profile arrays. Our results demonstrate that ML-EM-ATN and Chang1 result in improved uniformity, as measured by the S/L ratio.< <ETX xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&gt;</ETX>

Success Rates of Unilateral vs. Bilateral Cataract Extraction in Dogs

Postoperative results of 113 unilateral and 77 bilateral extracapsular cataract extractions (EC-CEs) in dogs were evaluated retrospectively. Restoration or improvement of functional vision was achieved in 79.6% of the eyes in dogs with unilateral extraction and 85.7% of the eyes in dogs with bilateral extractions at weeks 4 to 6. Complications occurring 6 weeks to 9 months after lens extraction lessened the surgical success rate in both groups. Twenty-six percent of the dogs in which bilateral lens removal was performed suffered complications resulting in surgical failure in one eye. When using the criterion that one or both treated eyes had functional vision, a short-term success rate of 98.7% was found for bilateral extractions.

Ocular blood flow in dogs using radiolabelled microspheres

We used radioactive microspheres of different sizes to determine the rate of blood flow through the various parts of the eye in dogs. The use of either 15 ± 5 μm or 25 ± 5 μm microspheres gave reproducible measurements of total ocular and uveal blood flows. Using these sphere sizes, retinal flow was found to be close to 1% of the total ocular blood flow and showed poor reproducibility due in part to the small number of spheres trapped in the retinal vessels.

DISTRIBUTION OF SULFANILAMIDE AND ITS DERIVATIVES BETWEEN BLOOD AND AQUEOUS

There are abundant reports in the literature suggesting that sulfanilamide and its derivatives may revolutionize therapy in ophthalmology as they have in general medicine. It is the purpose of this study to investigate the diffusion of various sulfanilamide compounds into the eye, to evaluate the importance of paracentesis as a means of raising the level of the drug in the aqueous and to determine the correlation between data on animals and on human beings. In the treatment of intraocular infections it would seem important to know approximately the concentration of the chemotherapeutic agent that can be obtained in the aqueous. The studies reported here were carried out in the hope of amplifying this knowledge. Investigations have been made by Bellows and Chinn¹on the diffusion of sulfanilamide, sulfapyridine (2-[paraaminobenzenesulfonamido]-pyridine) and sulfathiazole (2-[paraaminobenzenesulfonamido]-thiazole) in the eye in dogs and by Meyer, Bloch and Chamberlain²on the diffusion of sulfapyridine